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Abstract
Analysis of differential expression has been a central role to address the variety of bio-
logical questions in the manner to characterize abnormal patterns of cellular and molecu-
lar functions for last decades. To date, identification of differentially expressed genes 
and isoforms has been more intensively focused on temporal dynamics over a series of 
time points. Bayesian strategies have been successfully employed to uncover the com-
plexity of biological interest with the methodological and analytical perspectives for the 
various platforms of high-throughput data, for instance, methods in differential expres-
sion analysis and network modules in transcriptome data, peak-callers in ChipSeq data, 
target prediction in microRNA data and meta-methods between different platforms. In 
this chapter, we will discuss how our methodological works based on Bayesian models 
address important questions to arise in the architecture of temporal dynamics in RNA-
seq data.
Keywords: hierarchical Dirichlet Bayesian mixture model, Poisson Gamma auto 
regressive model, temporal dynamics, RNA-seq
1. Introduction
The differential expression analysis across external conditions (e.g. drug treatments, or 
between- or within-cell/tissue types) in stimuli-response data has long been crucial part on 
clinical applications [1–11]. The primary goal of these studies is to target therapeutic effects 
on genes and their pathways that are highly associated with the alterations between differ-
ent conditions, corresponding underlying biological mechanisms, and condition-specific 
molecular processes from microarray until recent RNA-seq platform [1–3, 5, 6, 9–43]. Such 
substantial effects on transcriptome data involved by various types of human diseases have 
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significantly addressed fundamental issues characterized by biological phenomena in tran-
scriptional regulation. For instance, examination of classification of subtypes on hereditary 
breast and ovary cancer [44–46], reciprocal phylogenetic conservation and heterogeneity 
between closest animal models of aging and depression in brain tissues [47–49], identification 
of differential expression on enzyme effect in Gaucher’s disease across distinct three tissues 
[14, 50], developmental transient patterns in mouse embryonic stem cells in pre-frontal cortex 
and limb tissues [13, 51], and et cetera.
The characterization based on Bayesian strategies for whole-genome wide transcriptome data 
and other types of Seq data has been successfully addressed on the variety of questions to 
arise in biomedical community [8, 9, 52]. As a naïve Bayesian method, baySeq framework 
has been proposed in differential expression analysis between different groups with rep-
licates [52]. ShrinkBayes has been developed to identify differential expression analysis at 
static data on the basis of zero-inflated Poisson Gamma model and Integrated Nested Laplace 
Approximation to estimate shrunken parameters [53]. And another Bayesian technique in 
ChipSeq, BayesPeak has been developed to detect significantly enriched regions in transcrip-
tion factor binding sites and histone modification datasets. It is on the basis of Bayesian hid-
den Markov model strategy and MCMC simulations with Poisson Gamma distribution to 
take into account over-dispersion in the abundance of read counts in different regions by 
comparing to the existing methods of peak callers in ChipSeq data, MACS, PeakSeq, and 
ChipSeq Peak Finder [54]. Additionally, Bayesian approaches to define differential expres-
sion of alternative splicing in RNA-seq have been proposed by MISO (as known as mixture of 
isoforms) model and MATS (as known as multivariate analysis of transcript splicing) [9, 18, 
55]. MISO method is to estimate differential expression of alternatively spliced exons and iso-
forms based on Bayes factor to quantify the odds of differential regulation of given isoform for 
the ratio of inclusion and exclusion levels. Similarly, MATS (and rMATS) is implemented to 
test differential alternative splicing patterns by estimating exon inclusion levels between two 
samples without (and with replicates), respectively. In addition, microRNAs target prediction 
methods that play a key regulatory role in gene regulation on the variety of biological pro-
cesses in human diseases, especially, cancer development, have been proposed by Bayesian 
methods [56, 57]. And also, Bayesian network methods have been proposed to predict the 
important functions of long non-coding RNAs as well as coding genes in RNA-seq [58, 59]. 
Thus, RNA-seq has become the alternative in transcriptome studies with advantageous fea-
tures over arrays, dynamic range of expression signals, higher reproducibility and quality 
on samples and upgraded annotation without any known priori [3, 16, 19, 20, 24, 26–28, 32].
With the strength on improvements on technology and continuously declining cost to 
sequencing, RNA-seq enables to facilitate to perform more dense experimental designs such 
as time course data with abundant resources of dynamic gene regulation. Furthermore, tran-
scriptome data and other types of meta-framed data across different platforms will be more 
popularly investigated in years to come. Indeed, next generation sequencing technologies 
have been steadily improved with higher throughput, longer reads, deeper sequencings, 
larger samples size of replicates, and less biases on data. Such advances allow investigators to 
conduct more complex experimental studies, various types of time course experiments, such 
as single series of longitudinally measured time course and transient dynamic patterns in 
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developmental stages; multi-series of factorial time course with multiple external conditions 
at each time point; cell-cyclic periodical data with (or without) external stimuli [7, 8, 22, 23, 
29, 30, 60].
To date, despite the substantial potential and significance to explore temporal dynamics at 
genes and other genomic features in various human disease progressive models and thera-
peutic effects, the lack of analytical methodologies in order to precisely characterize temporal 
dynamics has been an important challenging issue to better understand biological mecha-
nisms relevant with both time specific and responsively altered changes by given external 
stimulus.
In this chapter, we propose Bayesian approaches to better infer differential expression in 
temporal and spatial dynamic regulation that can be widely adopted in the community of 
biomedical research such as pediatric disease progressive models, age-related neurodegen-
erative diseases, other types of longitudinal and multi-series of time course data.
2. Methods
2.1. Data types of time course experiments
Dynamic gene regulation within a time window in transcriptome data is generally subcat-
egorized into (1) within-subject longitudinally repeatedly measured stimuli-response data 
in a single series of time course experiment, (2) between-subject factorial multi-series of time 
course data with different conditions at each time point, and (3) periodical data in cell-cycle 
or circadian rhythmic patterns with or without external conditions. For the first type of tem-
poral dynamics, we initially proposed Bayesian Poisson Gamma (negative binomial model) 
strategy to identify temporally differentially expressed genes in the previous study [23]. In 
this model, each gene is statistically tested whether it is equal or differential expression by 
auto-regressive (AR) model. The detailed description for notations is given in the following,
Model I: supposedly, a gene expression profile across a series of multiple time points,  y 
grt
 is 
independently distributed as Poisson Gamma (negative binomial model to account for vari-
ability of biological replicates within a group),  g = 1, 2, … , G (gene or other genomic feature), 
t = 1, 2, … , T (time point), and  r = 1, 2, … , R (biological replicate at each time point),
  y 
grt
 ~POI ( μ grt ) , 
  log  ( μ grt )  =  w grt +  β g , 
  w 
gr1
 ~N (0,  
 σ 2  _____ 
1 −  ϕ 
gr1
 2 ) , 
  w 
grt
  ∣  w 
gr,1,2,…,t−1 ~N ( ϕ gr1 ∗  w grt−1,   σ 2 ) , t > 2 
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In this proposed model,  β 
g
 is assumed to have non-informative priors and time series ran-
dom effects model for sequentially measured single series of time course data is assumed. To 
update the defined auto-regressive model and estimate the posterior probabilities of given 
parameter sets, we employ Markov Chain Monte Carlo simulations, N = 10,000 iterations and 
8000 burn-ins. To define temporal dynamics whether or not a given gene is temporally differ-
entially expressed, we further examine the most interesting parameter of auto-coefficient rep-
resenting time series sequential random effects in this proposed model. To classify between 
equal and differential expression, we implemented to compute Bayesian credible interval 
estimates. This proposed model is implemented by OpenBUGS (WinBUGS) in R (submit-
ted paper). Basically, it allows us to include major factor of time and variability of replicates 
at each time point and this simple linear auto-regressive (AR) model is straightforwardly 
extended to identify temporally differentially expressed other genomic features, for instance, 
quantified abundance of transcripts. Despite the much better improved quality of samples in 
RNA-seq data when compared to the beginning of technology, the preprocessing and nor-
malization procedures are still required to precisely infer temporally differentially expressed 
genes and isoforms and to reduce the misleading results in subsequent analyses. And some 
samples are discarded in the preprocessing step such as due to sample preparation in experi-
ments and the rest of corresponding samples for the given missing sample should be also 
deleted as it is the method for longitudinal data with repeated measurements across the series 
of time points. More importantly, RNA-seq data is highly skewed expression data toward to 
zero and low expression levels than high expression level. Collectively, in the format of longi-
tudinally measured experimental designs in temporal dynamics of RNA-seq data, as further 
improved strategy, we are currently developing a zero-inflated Poisson Gamma model with 
missing observations in longitudinal data to improve the capability of detection of temporal 
changes in highly skewed count data [61, 62]. The detailed descriptions and notations are 
given in the following, we consider the conditional distribution of  y 
grt
  ∣  E 
grt
 ,
  y 
grt
  ∣  E 
grt
  ∼ POI ( μ grt ) , if  E grt  = 1 
and
  P (   y grt  = 0 | E grt  = 0)  = 1 if  E grt  = 0 
where  E 
grt
 is the binary indicator of whether a gene expression profile across a series of mul-
tiple time points is present for a gene g, time t and replication r. We also assume that con-
ditioned on  p 
grt
 , the  E 
grt
 ’s are independent Bernoulli random variables with  P ( E grt  = 1)  =  p grt for 
 g = 1, 2, … , G ,  t = 1, 2, … , T , and  r = 1, 2, … , R . Here, given  E 
grt
  = 1 , assume that the  y 
grt
 ’s are condition-
ally independent.
Compared to arrays, the major strength of RNA-seq transcriptome data enables to quantify 
and identify spliced isoforms as well as individual exon-level expression which had not been 
previously done due to low resolution [8–11, 13, 14, 25, 28, 30, 33, 35, 60, 63–68]. In addition 
to gene level analyses, it is well established that alternative splicing is a prevalent mechanism 
on the variety of organisms. It involves multiple selective schemes of splice sites to construct 
diverse functional pathways and protein structures in gene regulation. A single mRNA may 
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code for different forms of a protein (isoform) as a result of alternative splicing that increases 
the complexity of mammalian transcriptome.
In the previous literatures, deep sequencing based transcriptome data predicts that more 
than ~95% of human genes typically contain multi-exons and transcript-variants to undergo 
alternative spliced events [8, 9, 25, 28, 33, 35, 63–65, 67]. The aberrant alternative splicing 
events occurring in post-transcriptional and translational procedures are highly associated 
with different tissues- or developmental stages- or environmental condition-specific manner. 
It has been investigated that malformation and dysfunctional mechanisms by the majority 
of abnormal alternative splicings in human brain diseases. Aberrant patterns of splicings 
in neurodegenerative Alzheimer’s patients and other types of pediatric cancer progres-
sion could be significant contributors to targeted therapies on disease progressive models 
and developmental evolutionary processes in transcriptional activity in temporal dynam-
ics [28, 63–66]. Despite the importance of alternative splicing events in recent technology, 
characterization of dynamic processes has been merely limited to gene level and static data 
approaches.
In the methodological point of view, for quantification and identification of isoforms, a couple 
of bioinformatics tools including IQSeq, rSeq, MapSplice have been recently developed [15, 
17, 31], and identification of differentially expressed isoforms at static data types have been 
pursued by MATS (focused on a specified experimental design on a sample versus another 
single sample comparison at a fixed time point) [9], DEXSeq (flexibly to allow various types of 
experimental and biological conditions in generalized linear model from the basis of multiple 
comparisons at exon levels) [5], and cufflinks and cuffdiff (as known as on the of most popular 
versatile tools for quantification and identification of differential expression at isoform levels, 
but restricted to simple pairwise comparison with replicates) [10, 11, 30, 68].
To our best knowledge, none of current static and dynamic methods can identify temporally 
differentially expression at alternative splicing by explicitly accounting for data-driven nature 
of various time course experimental settings.
For the first type of longitudinal time course experiments, quantified expression levels at iso-
forms and other types of genomic features can be directly applied for our proposed dynamic 
AR model.
For the second type of between-subject factorial multi-series of time course data, another our 
previous study [8] proposed a hierarchical Bayesian modeling approach to define differential 
expression analysis at isoforms when having multiple conditions at each time point, such as 
different tissues, drug treatments, stress, and trauma in temporal dynamics (see Figure 1).
Model II: the detailed description for notations in the proposed model is given in the fol-
lowing, for the sake of consistency in notations of the proposed models, we pursue Bayesian 
hierarchical Dirichlet Bayesian mixture model of temporal dynamics in multi-series of time 
course data by making use of the identical notations on the transcriptomic expression levels 
as shown in the Model I. Suppose that a gene (or other genomic feature) expression profile 
across a series of multiple time points is tested and each time point contains different external 
conditions, such as different types of tissues, cell lines, drug treatments, trauma, stress, and et 
cetera, where we denote a condition factor,  c = 1, 2, … , C at each time point.
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For a particular time point at T = t, and condition at C = c, the given expression level is given 
by  y 
grtc
 , g = 1, 2, … , G  (gene),  r = 1, 2, … , R (replicate at each time point and a condition),  t = 1, 2, … , T 
(time point), and  c = 1, 2, … , C (external condition at each time point). Let  γ 
g
 be a latent variable 
to be estimated in a hierarchical mixture model whether equal expression (EEX) or temporally 
differentially expression (TDEX) is at a given gene of interest. At a given time point T = t, 
τ 
g
 denotes the gth gene effect,  β 
c
 denotes the effect of the cth condition. The latent variable 
γ 
g
 represents an indicator variable such that the given gth gene is temporally differentially 
expressed or not, that is,  γ 
g
  =  { 1, when TDEX   0, when EEX  .
  y 
grtc
  ∣  γ 
g
  = d~POI ( μ grtc ) , 
  log  ( μ grtc )  =  τ g +  β c + F (β) +  w grtc , 
  β 
c
 ∣  l 
g
  = l~F ( β l ) , 
  l represents distinct patterns between conditions across time points, 
  Namely,  l 
g
  = l iff gth gene belongs to cluster l, 
  Let L denote the number of clusters on expression data, 
Figure 1. It depicts the latent variable to be estimated in hierarchical Dirichlet Bayesian mixture model.
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  n 
g
  =  | {g;  l g  = l} | denote the size of the lth cluster, 
  F (β) ~DP ( F 0 (F (β) ) ;  η 0 ) , 
  w 
grtc
  ∣  ( r g  = d,  l g  = l) ~DP ( G d ∗ ; M) , 
where DP(H; α ) stands for the Dirichlet process having its baseline distribution H( ∙ ) and mass 
parameter  α. And,  F 
0
 represents the mixture format of  β with p( β ) =  N 
G−1 (0,  ψ 0 ) such that  G 0 ∗ ~N (0,  σ 2 )  for equal expression (EEX) and  G 
1
 ∗ ~ 
1
 
__
2
 N (− δ,  σ 2 ) +  1 __
2
 N (δ,  σ 2 ) for differential expression (DEX) and  η 
0
 ,  ψ 
0
 ,  
and M are fixed hyper-parameters based on prior information [6, 69]. Therefore, the poste-
rior probability is given by, P( γ 
g
  = d ∣  l 
g
  = l,  y 
g111
 , … ,  y 
g,r=R,t=T,c=C ) for the temporally differentially expressed gene.
Based on our proposed Bayesian approach for multi-series of factorial time course data, we 
are currently implementing OpenBUGS(WinBUGS) in R to perform differential expression 
analysis. In order to validate our proposed model, we need to compare to other maSigPro for 
RNA-seq data and Gaussian Process modeling approach in terms of temporally differentially 
expressed genes in the multiple datasets after transformation of stabilizing variance on counts 
data.
3. Closing remarks in future directions
In earlier sections, we have discussed Bayesian techniques to address different types of 
experimental (clinical) settings in temporal dynamics by focusing on Poisson Gamma auto-
regressive model for longitudinally measured single-series of time course data and hierarchi-
cal Dirichlet Bayesian mixture model framework for multi-series of factorial time course data, 
respectively. Thus, as the continuous efforts to modeling approaches, we propose differential 
expression analytical frameworks that precisely characterize temporal dynamics for each type 
of stimuli-response data in this chapter.
The novel features in the proposed hierarchical Dirichlet Bayesian mixture model enables 
to identify significant temporal changes of expression levels between at least two external 
conditional factors over a series of time points based on Bayesian strategy grouping clusters 
by the patterns of differential or equal expression [6, 69]. The identified temporal changes are 
determined as the putative biomarkers that could be relevantly linked with various dynamic 
genetic mechanisms of molecular and physiological processes. Additionally, our proposed 
method enables to allow more than two genetic and environmental factors within a time 
point and to address how the intra-factor of multiple conditions and time factor affect altered 
expression patterns as significant contributors independently and interactively. Furthermore, 
this proposed model is straightforwardly extended to detect temporal changes at other 
genomic levels such as transcripts and exon levels.
Bayesian Modeling Approaches for Temporal Dynamics in RNA-seq Data
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As the extension of this study, we are currently developing how to measure the relation-
ship of a parent gene-to-multiple child isoforms in temporal dynamic patterns. For the 
task of this procedure, we carry out directional comparison, gene-to-isoform in differen-
tial expression based on similarity and discrepancy on magnitude and pattern of expres-
sion. This proposed model enables to define connectivity visualization of splicing maps on 
the variety of structural formations by switchable exon usage. Moreover, we are currently 
developing differential expression method for cell-cyclic periodical data with or without 
external conditions in stimuli-response data [70]. Thus, this proposed study is timely cru-
cial to define temporal dynamics at alternative splicing diversity related with disease pro-
gression by discovering which splicing events are condition and time specifically observed 
and how eventually their spliced abnormal patterns and splicing maps are associated with 
biological functions. And it is essential to develop strategies to correct aberrant splicing as 
well as gene approaches in temporal and spatial dynamics on the variety of disease pro-
gression and evolutionary comparative studies between human diseases and other closely 
related species.
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